欧洲药械组合市场 – 行业趋势及 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Drug Device Combination Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

欧洲药械组合市场 – 行业趋势及 2028 年预测

  • Healthcare
  • Published Report
  • Sep 2021
  • Europe
  • 350 页面
  • 桌子數： 85
  • 图号： 46
  • Author : Sachin Pawar
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Europe Drug Device Combination Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 3,142.68 Million USD 6,359.42 Million 2020 2028
Diagram Forecast Period
 2021 –2028
Diagram Market Size (Base Year)
 USD 3,142.68 Million
Diagram Market Size (Forecast Year)
 USD 6,359.42 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

欧洲药物-设备组合市场，按产品（自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等）、应用类型（骨科疾病、呼吸系统疾病、糖尿病、肿瘤学、心血管疾病等）、最终用户（诊所、医院、家庭护理机构、门诊护理中心等）、分销渠道（直接招标、零售销售等）、国家（英国、德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、比利时、土耳其和欧洲其他地区）划分的行业趋势和预测到 2028 年。

欧洲药械组合市场市场分析与洞察：欧洲药械组合市场

预计药械组合市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，市场复合年增长率为 9.7%，预计将从 2020 年的 31.4268 亿美元增至 2028 年的 63.5942 亿美元。先进和发达的医疗保健系统是预测期内推动药械组合产品需求的主要驱动力。

慢性病患病率的上升和技术的进步有效地促进了药物-器械组合市场的增长。然而，医疗器械的局限性和复杂性可能会阻碍药物-器械组合市场未来的增长。主要市场参与者的伙伴关系和合作为药物-器械组合市场的增长提供了机会。然而，严格的监管框架对药物-器械组合市场的增长构成了挑战。

药物-器械组合市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入领域、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。   

欧洲药械组合市场欧洲药物-设备组合市场 - 范围和市场规模

药物-器械组合市场根据产品、应用、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据产品，药械组合市场细分为自动注射器、微针贴片、数字药丸、智能吸入器、药物输送水凝胶、药物洗脱镜片等。自动注射器进一步细分为可穿戴自动注射器、手持式自动注射器。随着家庭护理环境和自我给药的采用率上升，预计到 2021 年，自动注射器将主导药械组合市场。
  • 根据应用，药械组合市场细分为骨科疾病、呼吸系统疾病、糖尿病、肿瘤科、心血管疾病等。2021 年，由于老年人口增加和政府对药械组合产品的资助，预计骨科将主导药械组合市场，从而加速市场增长。
  • 根据最终用户，药械组合市场细分为诊所、医院、家庭护理机构、门诊护理中心等。预计 2021 年诊所将主导药械组合市场，因为患者需要专家进行个性化护理和管理慢性病。
  • 根据分销渠道，药械组合市场分为直接招标、零售和其他。2021 年，直接招标预计将主导药械组合市场，因为它与最终用户直接互动，从而提高了可及性、可负担性和可用性。

 药物-器械组合市场 - 国家层面分析

对药物-设备组合市场进行分析，并按产品、应用、最终用户和分销渠道提供市场规模信息。

药物-设备组合市场报告涵盖的国家包括英国、德国、法国、西班牙、意大利、荷兰、瑞士、俄罗斯、土耳其、比利时和欧洲其他国家。   

由于欧洲拥有高科技医疗基础设施，且医疗支出不断增加，预计欧洲将在 2021 年至 2028 年的预测期内以显着的增长率增长。随着德国药物-设备组合行业的不断发展，德国在欧洲市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。  

药械组合市场参与者加强合作，为药械组合市场创造新机遇    

药物-器械组合市场还为您提供了每个国家在特定市场增长的详细市场分析。此外，它还提供有关市场参与者的战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期

竞争格局和药械组合市场份额分析

药物-器械组合市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对药物-器械组合市场的关注有关。

报告中涉及的主要参与者包括 Medtronic、Zimmer Biomet、Amgen Inc.、BD、Findair Sp. z oo、MetP Pharma AG、SONCEBOZ、Eitan Medical、Vaxess Technologies Inc.、Subcuject Aps、GlaxoSmithKline plc、Bayer AG、Sensirion AG Switzerland、Janssen Pharmaceuticals, Inc.（Johnson & Johnson Sevices, Inc. 的子公司）、Insulet Corporation、TheraJect、Otsuka America Pharmaceutical, Inc. 以及其他国内和欧洲参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地有许多公司发起合同和协议，这也加速了药械组合市场的发展。

例如，

  • 2020 年 7 月，Eitan Medical 旗下的 Sorrel Medical 与制药公司达成战略合作伙伴关系，以推进下一代可穿戴药物输送解决方案的开发和推出。这增强了公司的增长和创新能力。
  • 2020 年 8 月，Vaxess Technologies Inc. 宣布与生物医学高级研究与发展局 (BARDA) 签订合同，以评估替代疫苗接种技术。MIMIX 等创新平台的认可度不断提高，可以更好地应对未来的流行病，并将推动市场发展。

市场参与者的合作、合资和其他策略正在增强公司在药品-设备组合市场的影响力，为组织的增长速度提供了好处。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE DRUG-DEVICE COMBINATION MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. PATENT ANALYSIS
      1. MANUFACTURING PROCESS OF COMBINATION PRODUCTS
      2. APPROVAL BY AGENCY
      3. PATENT GRANT
      4. PATENT CERTIFICATIONS:
  5. Pipeline analysis
  6. REGULATORY FRAMEWORKS:
    1. U.S.
    2. EUROPE
    3. CANADA
    4. AUSTRALIA
    5. JAPAN
    6. CHINA
    7. SOUTH KOREA
  7. regional Summary
    1. North America Drug-Device Combination Market
      1. OVERVIEW
    2. Europe Drug-Device Combination Market
      1. OVERVIEW
    3. Asia-Pacific Drug-Device Combination Market
      1. OVERVIEW
    4. Middle East and Africa Drug-Device Combination Market
      1. OVERVIEW
    5. South America Drug-Device Combination Market
      1. OVERVIEW
  8. Market Overview
    1. Drivers
      1. INCREASING PREVALENCE OF chronic diseases
      2. Growing geriatric population
      3. Escalation in innovation and technologies
      4. Rising rates of obesity
    2. RESTRAINTS
      1. product recalls
      2. Risk associated with the combiNAtion products
    3. opportunities
      1. RISING EXPENDITURE ON HEALTHCARE
      2. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      3. Growing support by healthcare organizations and government bodies
      4. INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
    4. Challenge
      1. STRICT REGULATORY FRAMEWORK
  9. Impact Of COVID-19 Pandemic On The Europe Drug-Device Combination Market
    1. IMPACT ON PRICE
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON DEMAND
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. EUROPE DRUG-DEVICE COMBINATION MARKET, By product
    1. overview
    2. Auto-Injector
      1. WEARABLE AUTO-INJECTOR
      2. HAND HELD AUTO-INJECTOR
    3. Microneedle Patch
    4. digital pill
    5. Smart Inhaler
    6. Drug Delivery Hydrogels
    7. Drug-Eluting Lens
    8. others
  11. EUROPE DRUG-DEVICE COMBINATION MARKET, By application
    1. overview
    2. Orthopedic Diseases
    3. Respiratory Diseases
    4. Diabetes
    5. Oncology
    6. Cardiovascular Diseases
    7. others
  12. Europe drug-device combination MARKET, BY end user
    1. overview
    2. clinics
    3. hospitals
    4. home care settings
    5. ambulatory care centers
    6. others
  13. Europe drug-device combination MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retails sales
    4. others
  14. EUROPE drug-device combination MARKET, BY REGION
    1. Europe
      1. germany
      2. france
      3. u.k.
      4. italy
      5. spain
      6. russia
      7. switzerland
      8. turkey
      9. belgium
      10. netherlands
      11. rest of europe
  15. Europe Drug-device combination Market: COMPANY landscape
    1. company share analysis: Europe
  16. Swot analysis
  17. Company profile
    1. Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. Recent development
    2. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTs
    3. GlaxoSmithKline plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. recent developmentS
    5. MEDTRONIC
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Bayer AG
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. CGBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. CosMED Pharmaceutical Co.Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. E3D Elcam Drug Delivery Devices
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Eitan Medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. EOFLOW CO., LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Findair Sp. z o. o.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Insulet Corporation
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. Mediprint
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. MetP Pharma AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Micron Biomedical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. NanoPass
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    18. OcuMedic
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Otsuka America Pharmaceutical, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. PROPELLER HEALTH
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    21. RAPHAS CO., LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    22. Sensirion AG Switzerland
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
    23. . SONCEBOZ
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    24. Subcuject Aps
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    25. TheraJect
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    26. Vaxess Technologies Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    27. VAXXAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    28. YPSOMED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    29. Zimmer Biomet
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
  18. questionnaire
  19. related reports

表格列表

TABLE 1 Europe DRUG-DEVICE COMIBINATION Market, pipeline analysis

TABLE 2 Most obese countries of Asia-Pacific 2020

TABLE 3 EUROPE DRUG-DEVICE COMBINATION MARKET, By Product, 2019-2028 (USD million)

TABLE 4 Europe Auto-Injector in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 5 Europe Auto-Injector in Drug-Device Combination Market, By Product, 2019-2028 (USD Million)

TABLE 6 Europe Microneedle Patch in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 7 Europe Digital Pill in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 8 Europe Smart Inhaler in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 9 Europe Drug Delivery Hydrogels in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 10 Europe Drug-Eluting Lens in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 11 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 12 Europe Drug-Device Combination Market, By Application, 2019-2028 (USD Million)

TABLE 13 Europe Orthopedic Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 14 Europe Respiratory Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 15 Europe Diabetes in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 16 Europe Oncology in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 17 Europe Cardiovascular Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 18 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 19 Europe drug-device combination Market, By end user, 2019-2028 (USD MILLION)

TABLE 20 Europe clinics in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 21 Europe hospitals in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 22 Europe home care settings in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 23 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 24 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 25 Europe drug-device combination MARKET, By distribution channel 2019-2028 (USD MILLION)

TABLE 26 Europe direct tender in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 27 Europe retail sales in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 28 Europe others in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 29 EUROPE DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)

TABLE 30 EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 31 EUROPE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 32 EUROPE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 33 EUROPE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 34 EUROPE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 35 GERMANY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 36 GERMANY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 37 GERMANY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 38 GERMANY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 39 GERMANY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 FRANCE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 41 FRANCE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 42 FRANCE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 43 FRANCE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 44 FRANCE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 45 U.K. DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 46 U.K. AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 47 U.K. DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 48 U.K. DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 49 U.K. DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 50 ITALY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 51 ITALY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 52 ITALY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 53 ITALY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 54 ITALY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 SPAIN DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 56 SPAIN AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 57 SPAIN DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 58 SPAIN DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 59 SPAIN DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 RUSSIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 61 RUSSIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 62 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 63 RUSSIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 64 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 66 SWITZERLAND AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 67 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 68 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 69 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 70 TURKEY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 71 TURKEY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 72 TURKEY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 73 TURKEY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 74 TURKEY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 75 belgium DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 76 BELGIUM AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 77 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 78 BELGIUM DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 79 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 80 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 81 NETHERLANDS AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 82 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 83 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 84 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 REST OF EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

图片列表

FIGURE 1 EUROPE DRUG-DEVICE COMBINATION MARKET: segmentation

FIGURE 2 EUROPE DRUG-DEVICE COMBINATION MARKET: data triangulation

FIGURE 3 EUROPE DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS

FIGURE 4 EUROPE DRUG-DEVICE COMBINATION MARKET: Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE DRUG-DEVICE COMBINATION MARKET: Multivariate Modelling

FIGURE 7 EUROPE DRUG-DEVICE COMBINATION MARKET: PRODUCT type LIFELINE CURVE

FIGURE 8 EUROPE DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 EUROPE DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID

FIGURE 10 EUROPE DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 EUROPE DRUG-DEVICE COMBINATION MARKET: vendor share analysis

FIGURE 12 EUROPE DRUG-DEVICE COMBINATION MARKET: SEGMENTATION

FIGURE 13 THE increasing prevalence of chronic diseases and rising geriatric population are expected to drive THE EUROPE DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 14 THE Auto-Injector segment is expected to account for the largest share of the EUROPE DRUG-DEVICE COMBINATION MARKET IN THE Year 2021 & 2028

FIGURE 15 Porter's 5 forces

FIGURE 16 Pestel's Model

FIGURE 17 DRIVERS, RESTRAINTS, Opportunities, and Challenges: EUROPE DRUG-DEVICE COMBINATION MARKET

FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.

FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE

FIGURE 20 AGEING POPULATION In the world (in millions)

FIGURE 21 North AMERICA AGEING POPULATION (In million)

FIGURE 22 Europe AGEING POPULATION (In million)

FIGURE 23 Asia-pacific AGEING POPULATION (In million)

FIGURE 24 Medical Device Spending vs. National Health Expenditures, 2016

FIGURE 25 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2020

FIGURE 26 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2019-2028 (USD million)

FIGURE 27 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, CAGR (2021-2028)

FIGURE 28 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, LIFELINE CURVE

FIGURE 29 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2020

FIGURE 30 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2019-2028 (USD million)

FIGURE 31 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, CAGR (2021-2028)

FIGURE 32 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, LIFELINE CURVE

FIGURE 33 Europe drug-device combination MARKET: BY END USER, 2020

FIGURE 34 Europe drug-device combination MARKET: BY product, 2021-2028 (USD MILLION)

FIGURE 35 Europe drug-device combination MARKET: BY product, CAGR (2021-2028)

FIGURE 36 Europe drug-device combination MARKET: BY product, LIFELINE CURVE

FIGURE 37 Europe drug-device combination MARKET: BY distribution channel, 2020

FIGURE 38 Europe drug-device combination MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 39 Europe drug-device combination MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 40 Europe drug-device combination MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 41 EUROPE DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)

FIGURE 42 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)

FIGURE 43 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 44 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 45 EUROPE DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)

FIGURE 46 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

The Europe Drug-Device Combination Market thrives at a CAGR of 9.7% during its forecast period of 2022 to 2028.
The Europe Drug-Device Combination Market value flourishes with $6,359.42 million by 2028.
The geographical locations considered in the study of the report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium, and the rest of Europe.
Germany is now leading the Europe Drug-Device Combination Market rapidly due to the increasing advancement in the drug-device combination industry in the region.

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future